31 August 2023

Check Up #17 - What distinguishes cancer epidemiology and aetiology and why is each important?

But this doesn’t mean these two areas are totally distinct. In fact, epidemiology also deals with the causes of disease. But while epidemiology involves the study of determinants and distribution of disease, aetiology attempts to confirm the causes.

Paulo Cardoso Correia da Mota Pinto

Maria Isabel Barroso Lopes Soares

10 August 2023

Check Up #16 - What is cancer chemoprevention and when does it apply?

That said, this definition has been widening throughout the years to include potential chemopreventive substances that are not necessarily drugs. So-called “nutraceuticals”, such as dietary fiber, prebiotics, probiotics, polyunsaturated fatty acids, antioxidants (such as vitamins) and different types of herbal or natural foods (dietary supplements) are also being studied for cancer chemoprevention. However, to date, the efficacy of these substances has not been confirmed.

28 Jul. 2023

Histopathology Platform - Junior Digital Pathology Scientist

Institutional
Application Starts: 01 Aug. 2023
Application Ends: 05 Aug. 2023

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Junior Digital Pathology Scientist to join our Histopathology Platform team, at the Champalimaud Research Programme. 

The selected candidate will

Work closely with senior experimental pathologists and laboratory staff to support a variety of research projects, in the field of digital pathology. Responsibilities will include:

01 August 2023

Zoom-In on Champalimaud - 3rd Edition - Issue 6

Since 2012, August 1 has been designated as World Lung Cancer Day. The international lung health community uses the day to raise awareness and spread information about the disease’s risk factors, symptoms, diagnosis and treatment.

Dr. Susana Simões, of the Champalimaud Foundation’s Lung Unit, joined us for a conversation about this disease, which is responsible for more cancer deaths than any other.

28 Jul. 2023

Research Grants Manager - Grants_SRD_Aug2023

Institutional
Application Starts: 28 Jul. 2023
Application Ends: 08 Sep. 2023

THIS RECRUITMENT PROCESS IS CLOSED.

 

Champalimaud Foundation is actively looking for a Research Grants Manager. You need to be passionate about science and ready to be challenged daily while you help bring some of the most promising research ideas in neuroscience, behaviour, physiology and cancer into reality.

19 July 2023

Zoom-In on Champalimaud - 3rd Edition - Issue 5

Around 600 million people around the world play chess, with 70% of adults having played at some point in their lives; and as 20th July is International Chess Day, we spoke to Champalimaud Researchers Carlos Stein Brito and T. Quendera to find out more about why they play and what the game means to them as scientists.

12 July 2023

Check Up #15 - What is therapeutic Nuclear Medicine

In CheckUp #14, we talked about the different types of cancer treatments with ionizing radiation: internal and external radiotherapies. We promised we would return to this subject to talk in more detail about a special type of internal radiotherapy: molecular radiotherapy. This activity is integrated in Nuclear Medicine, a medical specialty that, in Oncology, uses radiopharmaceuticals to diagnose, treat, and evaluate the response of cancers to existing or new drugs.

29 June 2023

Champalimaud Research Annual Retreat 2023

The 2023 retreat took place at the Grande Hotel do Luso, in the beautiful Serra do Buçaco, from 29 May to 1 June, with the participation of more than 250 CR members. The theme of this year’s retreat was Embracing Multitudes: a Game of Translation which aimed at building bridges between the diverse research areas of CR, from neuroscience, cancer biology and immunology, to translational clinical research. The focus was on the diversity that shapes our institute and how to create a cohesive and collaborative community.

Subscribe to People
Loading
Please wait...